Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase NA 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Specimen Handling 147 pembrolizumab 124 Magnetic Resonance Spectroscopy 114 Cyclophosphamide 114 Biopsy 104 fludarabine 84 Nivolumab 59 Carboplatin 54 Gemcitabine 46 Cisplatin 46 venetoclax 45 Radiotherapy 45 Paclitaxel 43 Ipilimumab 38 fludarabine phosphate 37 Cetuximab 37 Fluorouracil 34 atezolizumab 31 Bevacizumab 31 durvalumab 30 X-Rays 28 Oxaliplatin 28 Dexamethasone 28 Leucovorin 27 Radiation 26 Irinotecan 26 Azacitidine 25 Injections 24 Cytarabine 24 Radiosurgery 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Curcumin × 90 days × Clear all

NCT06626230 2026-05-18

Safety of Anal Curcumin

Emory University

Phase 1 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡